Enanta Pharmaceuticals, Inc.
ENTA
$13.02
$0.221.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.90% | -11.29% | -35.61% | -35.73% | -32.91% |
| Total Receivables | -82.19% | -79.43% | 2.11% | 0.64% | -2.46% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -30.80% | -32.90% | -18.98% | -19.34% | -6.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -31.85% | -22.29% | -30.81% | -31.30% | -29.08% |
|
|
|||||
| Total Current Assets | -31.85% | -22.29% | -30.81% | -31.30% | -29.08% |
| Net Property, Plant & Equipment | -0.55% | 12.99% | 31.35% | 130.23% | 111.29% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.06% | -0.32% | -16.77% | -27.02% | -27.60% |
| Total Assets | -25.47% | -24.52% | -21.90% | -18.64% | -18.52% |
|
|
|||||
| Total Accounts Payable | -75.66% | -66.77% | -29.29% | -49.32% | 95.31% |
| Total Accrued Expenses | -5.88% | -15.41% | -21.79% | -8.86% | -26.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.92% | -13.18% | -11.74% | -18.63% | -10.82% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -15.61% | -23.50% | -15.86% | -21.40% | -8.36% |
|
|
|||||
| Total Current Liabilities | -15.61% | -23.50% | -15.86% | -21.40% | -8.36% |
| Long-Term Debt | -17.40% | -15.36% | -15.06% | -14.34% | -15.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.51% | 15.62% | 30.23% | 175.06% | 153.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.55% | 11.01% | 8.48% | -63.79% | -65.16% |
| Total Liabilities | -12.84% | -11.27% | -7.27% | 0.09% | 0.94% |
|
|
|||||
| Common Stock & APIC | 4.08% | 4.99% | 5.34% | 5.63% | 6.27% |
| Retained Earnings | -25.35% | -31.27% | -35.50% | -43.65% | -56.06% |
| Treasury Stock & Other | -212.25% | 38.44% | 66.42% | 94.57% | 125.72% |
| Total Common Equity | -49.76% | -46.76% | -43.69% | -41.73% | -40.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -49.76% | -46.76% | -43.69% | -41.73% | -40.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -49.76% | -46.76% | -43.69% | -41.73% | -40.57% |
|
|
|||||